Evaluation of Image Quality of Overweight and Obese Patients in CT Using High Data Rate Detectors.

BACKGROUND/AIM: To evaluate the impact of high data rate and sampling frequency detector technology compared to standard scan equipment on the image quality in abdominal computed tomography (CT) of overweight and obese patients. PATIENTS AND METHODS: A total of 173 patients were retrospectively included in this study. Objective image quality in abdominal CT was evaluated using comparative analysis with new detector technology prior to market launch and standard CT equipment. Contrast noise ratio (CNR), image noise, volumetric computed tomography dose index (CTDIVol), and figures of merit (Q and Q1) were assessed for all patients. RESULTS: Image quality was superior in the new detector technology for all parameters evaluated. The dose dependent parameters Q and Q1 showed a significant difference (p<0.001). CONCLUSION: A significant increase in objective image quality could be demonstrated using a new generation detector setup with increased frequency transfer in abdominal CT of overweight patients.

Assessment of Image Quality in Chest CT With Precision Matrix and Increased Framing Rate Using Single Source CT: A Phantom Study.

BACKGROUND/AIM: The aim was to evaluate the effect of a combined precision matrix and high sampling rate on the delineation of anatomical structures and objective image quality in single source CT in a qualitative approach. MATERIALS AND METHODS: An anthropomorphic thoracic phantom was used to evaluate the objective image quality parameters, including image noise, noise power spectrum, image stepness and Q for different CT scanners including high/standard matrix and framing frequency setups. Scan parameters were standardized over all scanners. Additional subjective quality assessment was also performed. RESULTS: A linear mixed effects model was used to determine the effect of sampling rate and image matrix on objective image quality parameters. Noise power spectrum and image noise were significantly influenced by both framing frequency and image matrix. There were significant differences between high and standard frequency/matrix acquisitions. CONCLUSION: Higher framing frequency and image matrix allows for improved image noise texture and objective image quality in CT.

Bilateral pneumothoraces complicating reduction mammoplasty: a case report.

BACKGROUND: Bilateral pneumothoraces after cosmetic breast surgery are rare and sporadically reported in the literature. CASE PRESENTATION: A 65-year-old female patient developed bilateral pneumothoraces after bilateral breast reduction surgery. Emergent chest tube thoracostomy was performed on both sides. The chest drains were removed on the fourth day (left side) and sixth day (right side), and the patient was discharged after 7 days of hospitalization without any further complications. CONCLUSION: To our knowledge, the English-language literature contains no other reports of bilateral pneumothoraces after reduction mammoplasty.

Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.

We aimed to evaluate plasma plasminogen activator inhibitor-1 (PAI-1) antigen levels in women with polycystic ovary syndrome (PCOS) and different levels of adiposity and PCOS phenotypes. We studied 199 women with PCOS and 50 age-matched healthy women divided in normal weight (n=100 and n=25, respectively) and overweight/obese (n=99 and n=25, respectively). Normal weight and overweight/obese patients with PCOS were further divided in patients diagnosed according to the 1990 criteria (i.e. with anovulation and hyperandrogenemia; 1990 criteria group) and in patients with the additional phenotypes introduced in 2003 (i.e. with polycystic ovaries and either anovulation or hyperandrogenemia; additional 2003 criteria group). In normal weight subjects, plasma PAI-1 levels did not differ between women with PCOS (regardless of group) and controls, or between the 1990 criteria and the additional 2003 criteria groups of PCOS. In overweight/obese subjects, plasma PAI-1 levels were higher in both the 1990 criteria and the additional 2003 criteria groups of PCOS compared with controls (p<0.001 and p=0.004, respectively), but did not differ between the 1990 criteria and the additional 2003 criteria groups of PCOS. In conclusion, plasma PAI-1 levels are elevated in overweight/obese women with PCOS but not in normal weight women with this syndrome. Plasma PAI-1 levels do not differ between the phenotypes of PCOS.